SCHEMBL7308291

SCHEMBL7308291

CC(C)(CSc1ccc(C(=O)c2ccccc2)cc1)C(=O)NO

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 1/20 0.42
MAPK12 P53778 1/20 0.42
MAPK11 Q15759 1/20 0.42
MAPK14 Q16539 1/20 0.42
ABCC9 O60706 2/20 0.42
ABCC8 Q09428 2/20 0.42
KCNJ11 Q14654 2/20 0.42
PDK1 Q15118 2/20 0.42
PDK2 Q15119 2/20 0.42
PDK3 Q15120 2/20 0.42
KCNJ8 Q15842 2/20 0.42
PDK4 Q16654 2/20 0.42
ABCB11 O95342 1/20 0.42
HDAC1 Q13547 2/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7303734 0.85 PPARA (0.51) MAPK13MAPK12MAPK11MAPK14NPY5R
SCHEMBL7301182 0.73 MMP2 (0.54) MMP8MMP1MMP2MMP13ELANE
SCHEMBL11356807 0.73 ALDH1A1 (0.54) MAPK13MAPK12MAPK11MAPK14NPY5R
SCHEMBL7722382 0.72 ALDH1A1 (0.58) MAPK13MAPK12MAPK11MAPK14NPY5R
SCHEMBL11306067 0.72 ALDH1A1 (0.58) MAPK13MAPK12MAPK11MAPK14HDAC1
SCHEMBL2816778 0.71 FFAR1 (0.50) PPARAALDH1A1RAB9AL3MBTL1
SCHEMBL15007027 0.70 FFAR1 (0.70) MAPK13MAPK12MAPK11MAPK14NPY5R
SCHEMBL2026670 0.70 FFAR1 (0.48) ALDH1A1HPGDRAB9A
SCHEMBL27910293 0.70 ALDH1A1 (0.54) MAPK13MAPK12MAPK11MAPK14NPY5R
SCHEMBL15908065 0.69 ALDH1A1 (0.45) PPARAALDH1A1ELANEHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed